Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 1 2Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Papillomavirus Infections 4Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Sarcoma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Melanoma 1Lung Neoplasms 1Infertility, Female 1Elective Surgery for Any Digestive Cancer 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Ductal Infiltrating Metastatic 1Barrett Esophagus 1Airway Obstruction 1

Interventions

Doxorubicin 25Ifosfamide 22Radiotherapy 17Etoposide 11Vincristine 10Cyclophosphamide 10Filgrastim 8Dactinomycin 8Trabectedin 7Chemotherapy, Adjuvant 5pazopanib 4Cisplatin 4Topotecan 3Radiation 3Neoadjuvant Therapy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Dacarbazine 3sargramostim 2etoposide phosphate 2eribulin 2Observation 2Methotrexate 2Mesna 2Imatinib Mesylate 2Gemcitabine 2Epirubicin 2Docetaxel 2Dexrazoxane 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma × Blood Specimen Collection × Clear all
NCT06332274 2025-05-13

UMBRELLA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
717 enrolled
GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡